Hebei Changshan Biochem Pharma (300255) — Capital Reinvestment Ratio
Hebei Changshan Biochem Pharma (300255) has a Capital Reinvestment Ratio of 0.27x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥70.22 Million) in capital expenditures (CN¥18.63 Million). Check tangible equity quality of Hebei Changshan Biochem Pharma to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hebei Changshan Biochem Pharma Capital Reinvestment Ratio (2009–2024)
This chart tracks Hebei Changshan Biochem Pharma's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Hebei Changshan Biochem Pharma cash conversion from operations.
Annual Capital Reinvestment Ratio for Hebei Changshan Biochem Pharma (2009–2024)
Year-by-year Capital Reinvestment Ratio for Hebei Changshan Biochem Pharma from 2009 to 2024. See Hebei Changshan Biochem Pharma free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 4.26x | CN¥56.22 Million | CN¥239.59 Million | ▼ -39.9% |
| 2023 | 7.10x | CN¥33.73 Million | CN¥239.32 Million | ▼ -94.9% |
| 2022 | 137.97x | CN¥3.13 Million | CN¥431.22 Million | ▲ +28.6% |
| 2021 | 107.29x | CN¥2.87 Million | CN¥308.08 Million | ▲ +13277.0% |
| 2018 | 0.80x | CN¥292.81 Million | CN¥234.85 Million | ▼ -17.8% |
| 2017 | 0.98x | CN¥162.28 Million | CN¥158.30 Million | ▲ +73.8% |
| 2016 | 0.56x | CN¥171.96 Million | CN¥96.52 Million | ▼ -68.6% |
| 2011 | 1.79x | CN¥17.04 Million | CN¥30.43 Million | ▲ +39.0% |
| 2010 | 1.28x | CN¥29.25 Million | CN¥37.56 Million | ▲ +29.3% |
| 2009 | 0.99x | CN¥24.21 Million | CN¥24.05 Million | — |